Bio-Rad Provides Outlook Through 2023

Author's Avatar
Dec 11, 2020
Article's Main Image

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced today its outlook through 2023, which shows the company’s commitment to continued organic growth, continued margin expansion, and its efforts on sustainability measures.